Clinical Trials
3 trialsNCT04994626 2021-08-06
Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies
ChineseAMS
Phase 2 Unknown
NCT03947736 2019-05-14
Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR
ChineseAMS
Unknown
NCT01492556 2013-03-15
Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer
ChineseAMS
Phase 2 Unknown